Essential Hypertension
📧 Sign up to get email alerts when something new happens for Essential Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS other · 2026-02-10Clinical Trial Update: Engaging Home-monitored Assessment to Navigate Clinical Decision-making [NA]
Clinical trial update about a study evaluating home-monitored assessment to aid clinical decision-making in hypertension, currently enrollin…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Efficacy and Safety of DWC202404 and DWC202314 in Patients With Hypertension [Phase 3]
Phase 3 trial results report on the efficacy and safety of Daewoong's DWC202404 and DWC202314 in hypertension, with the study now completed.
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Specificity of Elevated Plasma EM66 Levels in Pheochromocytoma [NA]
A completed clinical trial from University Hospital, Rouen evaluated the specificity of elevated plasma EM66 levels for pheochromocytoma and…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Effect of Electrical Stimulation and Exercise on Blood Flow in Patients With Resistant High Blood Pressure [NA]
A clinical trial investigating whether electrical stimulation combined with exercise affects blood flow in patients with resistant hypertens…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: A Study of BR1400-1, BR1400-2, BR1400-3, BR1400-4, and BR1400-5 in Patients With Essential Hypertension [Phase 2]
Phase 2 clinical trial update for BR1400-1 through BR1400-5 in essential hypertension; the study has not yet begun recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Essential Hypertension (PARADISE HTN-III) [NA]
A clinical trial (NCT06283758) sponsored by Suzhou Municipal Hospital is currently recruiting to evaluate focused power ultrasound therapy t…
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: Safety and Pharmacokinetics Study of BCD101 in Healthy Volunteers [Phase 1]
Phase 1 safety and pharmacokinetics study of BCD101 in healthy volunteers is currently recruiting for essential hypertension.
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-202A [Phase 3]
Phase 3 trial to evaluate the efficacy and safety of CKD-202A in essential hypertension is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: Effects of Exogenous Ketosis on Renal Function, Renal Perfusion, and Sodium Excretory Capacity [NA]
This completed clinical trial from Gødstrup Hospital studied the effects of exogenous ketosis on renal function, renal perfusion, and sodium…
-
CLINICAL_TRIALS withdrawal · 2025-12-08Clinical Trial Update: Efficacy and Safety of Olmesartan Associated With Chlorthalidone Versus Benicar HCT® in Essential Hypertension Control [Phase 3]
A Phase 3 trial comparing olmesartan with chlorthalidone against Benicar HCT for essential hypertension has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: Sleep Hygiene Education and Blood Pressure Control in Essential Hypertension in Primary Care [NA]
A completed clinical trial evaluated sleep hygiene education as a strategy to improve sleep quality and help control blood pressure in adult…
-
CLINICAL_TRIALS withdrawal · 2025-12-08Clinical Trial Update: Efficacy and Safety of Olmesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control [Phase 3]
Phase 3 trial evaluating olmesartan with chlorthalidone for essential hypertension has been withdrawn.
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Childhood-Onset Essential Hypertension Natural History Study
The National Human Genome Research Institute is sponsoring a childhood-onset essential hypertension natural history study that is currently …
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Co-administrated BR1018B and BR1018C [Phase 3]
The document reports the completion of a Phase 3 clinical trial evaluating the efficacy and safety of co-administered BR1018B and BR1018C. T…
-
FDA approval · 2025-10-06FDA Approved: OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' generic triple-combination tablet of olmesartan medoxomil, amlodipine, and hydrochlorothiazide for esse…
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: To Evaluate the Efficacy and Safety of KN060 in Essential Hypertension [Phase 1]
A Phase 1 clinical trial is investigating KN060 for efficacy and safety in patients with essential hypertension, and the study is currently …
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: The Benefits of Natural Medicine, Vitamin IV Therapy and Supplements: Maintaining Good Health Through Nature
A clinical trial entry investigating natural medicine, vitamin IV therapy, and supplements for maintaining good health, currently recruiting…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Renal Artery Denervation Assessment Without Antihypertensive Medication Regimen (RADAR) [Phase 3]
Phase 3 clinical trial evaluating renal denervation for hypertension without antihypertensive medications; currently recruiting. Sponsor: Ab…
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: An OS to Evaluate Effectiveness and Safety of Fixed-dose Combinations of FMS/AML or FMS/AML/HCTZ
Clinical trial evaluating the effectiveness and safety of fixed-dose combinations FMS/AML or FMS/AML/HCTZ for essential hypertension; curren…
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Study to Evaluate and Compare the Efficacy and Safety of AZM and AML Combined and Alone in Mild-to-moderate Essential Hypertensive Subjects [Phase 3]
Phase 3 trial update from Celltrion evaluating AZM and AML, alone and in combination, for mild-to-moderate essential hypertension; the study…
-
CLINICAL_TRIALS trial_result · 2025-09-03Clinical Trial Update: A Phase I Trial of QLS1410 in Healthy Chinese Adults and Participants With Mild Essential Hypertension [Phase 1]
Phase I trial evaluating QLS1410 in healthy Chinese adults and individuals with mild essential hypertension; the study status is Not Yet Rec…
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: A Multicenter, Randomized, Double-Blind Phase 3 Trial of KDF1901 in Patients With Essential Hypertension [Phase 3]
A multicenter, randomized Phase 3 trial of KDF1901 for essential hypertension has completed, with a status update provided but no efficacy r…
-
CLINICAL_TRIALS research · 2025-07-04Clinical Trial Update: To Evaluate the Safety and Efficacy of a Single-Use IVUS Ablation for Primary Hypertension [NA]
A clinical trial is evaluating the safety and efficacy of a single-use IVUS-guided ablation device for essential hypertension; recruitment i…
-
CLINICAL_TRIALS research · 2025-06-19Clinical Trial Update: Safety and Efficacy of Modulated Ultrasound Renal Denervation for HTN（FIM） [NA]
A clinical trial evaluating the safety and efficacy of modulated ultrasound renal denervation for essential hypertension is currently recrui…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: A Study to Evaluate Efficacy and Safety of HGP2102 in Essential Hypertension Patients [Phase 3]
This entry notes that Hanmi's HGP2102 is in a Phase 3 trial for essential hypertension and is currently recruiting.